11/14
01:10 pm
bbnx
Beta Bionics (NASDAQ:BBNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Beta Bionics (NASDAQ:BBNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/3
04:08 pm
bbnx
Beta Bionics Announces Participation at Upcoming Investor Conferences
Low
Report
Beta Bionics Announces Participation at Upcoming Investor Conferences
11/1
01:05 am
bbnx
10/30
09:10 am
bbnx
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 [Yahoo! Finance]
Low
Report
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 [Yahoo! Finance]
10/29
10:08 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Beta Bionics (NASDAQ:BBNX) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
10/29
10:08 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $23.00 price target on by analysts at Robert W. Baird.
Medium
Report
Beta Bionics (NASDAQ:BBNX) was given a new $23.00 price target on by analysts at Robert W. Baird.
10/29
09:36 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $32.00 price target on the stock, up previously from $26.00.
Medium
Report
Beta Bionics (NASDAQ:BBNX) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $32.00 price target on the stock, up previously from $26.00.
10/29
09:05 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $31.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Beta Bionics (NASDAQ:BBNX) was given a new $31.00 price target on by analysts at Stifel Nicolaus.
10/29
09:04 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Medium
Report
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
10/29
09:04 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at Lake Street Capital. They now have a $35.00 price target on the stock.
Medium
Report
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at Lake Street Capital. They now have a $35.00 price target on the stock.
10/28
04:02 pm
bbnx
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
Medium
Report
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
10/21
08:03 am
bbnx
Beta Bionics (NASDAQ:BBNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $26.00 price target on the stock.
Low
Report
Beta Bionics (NASDAQ:BBNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $26.00 price target on the stock.
10/16
04:59 pm
bbnx
Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook [Yahoo! Finance]
Medium
Report
Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook [Yahoo! Finance]
10/9
08:00 am
bbnx
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
Low
Report
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
10/8
12:15 pm
bbnx
Beta Bionics (NASDAQ:BBNX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Beta Bionics (NASDAQ:BBNX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
10/2
07:19 am
bbnx
Beta Bionics (NASDAQ:BBNX) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "hold" rating to a "strong-buy" rating.
Low
Report
Beta Bionics (NASDAQ:BBNX) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "hold" rating to a "strong-buy" rating.
10/1
07:04 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $26.00 price target on by analysts at The Goldman Sachs Group, Inc..
Low
Report
Beta Bionics (NASDAQ:BBNX) was given a new $26.00 price target on by analysts at The Goldman Sachs Group, Inc..
9/22
11:03 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Truist Financial Corporation from $21.00 to $28.00. They now have a "buy" rating on the stock.
Low
Report
Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Truist Financial Corporation from $21.00 to $28.00. They now have a "buy" rating on the stock.
9/9
07:13 am
bbnx
Insiders See US$567.0k Investment In Beta Bionics Jump Last Week [Yahoo! Finance]
Medium
Report
Insiders See US$567.0k Investment In Beta Bionics Jump Last Week [Yahoo! Finance]